Shifa S Gandhi1, Colleen Muraresku2, Elizabeth M McCormick2, Marni J Falk2,3, Shana E McCormack4,5. 1. Robert Wood Johnson Medical School, Piscataway Township, NJ, USA. 2. Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. 3. Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 4. Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. mccormacks1@email.chop.edu. 5. Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Suite 11NW, Philadelphia, PA, 19104, USA. mccormacks1@email.chop.edu.
Abstract
INTRODUCTION: Primary mitochondrial disease is caused by either mitochondrial or nuclear DNA mutations that impact the function of the mitochondrial respiratory chain. Individuals with mitochondrial disorders have comorbid conditions that may increase their risk for poor bone health. The objective of this retrospective electronic medical record (EMR) review was to examine risk factors for poor bone health in children and adults with primary mitochondrial disease. METHODS: Eighty individuals with confirmed clinical and genetic diagnoses of primary mitochondrial disease at the Children's Hospital of Philadelphia (CHOP) were included in this study. Risk factors and bone health outcomes were collected systematically, including: anthropometrics (low BMI), risk-conferring co-morbidities and medications, vitamin D status, nutrition, immobility, fracture history, and, where available, dual energy x-ray absorptiometry (DXA) bone mineral density (BMD) results. RESULTS: Of patients 73% (n = 58) had at least one risk factor and 30% (n = 24) had four or more risk factors for poor bone health. The median number of risk factors per participant was 2, with an interquartile interval (IQI 0-4). In the subset of the cohort who were known to have sustained any lifetime fracture (n = 11), a total of 16 fractures were reported, six of which were fragility fractures, indicative of a clinically significant decrease in bone strength. CONCLUSIONS: The prevalence of risk factors for poor bone health in primary mitochondrial disease is high. As part of supportive care, practitioners should address modifiable risk factors to optimize bone health, and have a low threshold to evaluate clinical symptoms that could suggest occult fragility fracture.
INTRODUCTION:Primary mitochondrial disease is caused by either mitochondrial or nuclear DNA mutations that impact the function of the mitochondrial respiratory chain. Individuals with mitochondrial disorders have comorbid conditions that may increase their risk for poor bone health. The objective of this retrospective electronic medical record (EMR) review was to examine risk factors for poor bone health in children and adults with primary mitochondrial disease. METHODS: Eighty individuals with confirmed clinical and genetic diagnoses of primary mitochondrial disease at the Children's Hospital of Philadelphia (CHOP) were included in this study. Risk factors and bone health outcomes were collected systematically, including: anthropometrics (low BMI), risk-conferring co-morbidities and medications, vitamin D status, nutrition, immobility, fracture history, and, where available, dual energy x-ray absorptiometry (DXA) bone mineral density (BMD) results. RESULTS: Of patients 73% (n = 58) had at least one risk factor and 30% (n = 24) had four or more risk factors for poor bone health. The median number of risk factors per participant was 2, with an interquartile interval (IQI 0-4). In the subset of the cohort who were known to have sustained any lifetime fracture (n = 11), a total of 16 fractures were reported, six of which were fragility fractures, indicative of a clinically significant decrease in bone strength. CONCLUSIONS: The prevalence of risk factors for poor bone health in primary mitochondrial disease is high. As part of supportive care, practitioners should address modifiable risk factors to optimize bone health, and have a low threshold to evaluate clinical symptoms that could suggest occult fragility fracture.
Entities:
Keywords:
Bone mineral density; Dual energy x-ray absorptiometry; Fracture; Mitochondrial diseases; Osteopenia; Osteoporosis
Authors: Denise G M McDonald; Maria Kinali; Andrew C Gallagher; Eugenio Mercuri; Francesco Muntoni; Helen Roper; Philip Jardine; David Hilton Jones; M G Pike Journal: Dev Med Child Neurol Date: 2002-10 Impact factor: 5.449
Authors: E Michael Lewiecki; Neil Binkley; Sarah L Morgan; Christopher R Shuhart; Bruno Muzzi Camargos; John J Carey; Catherine M Gordon; Lawrence G Jankowski; Joon-Kiong Lee; William D Leslie Journal: J Clin Densitom Date: 2016-03-22 Impact factor: 2.617
Authors: Babette S Zemel; Mary B Leonard; Andrea Kelly; Joan M Lappe; Vicente Gilsanz; Sharon Oberfield; Soroosh Mahboubi; John A Shepherd; Thomas N Hangartner; Margaret M Frederick; Karen K Winer; Heidi J Kalkwarf Journal: J Clin Endocrinol Metab Date: 2010-01-26 Impact factor: 5.958
Authors: Rachel L Boal; Yi Shiau Ng; Sarah J Pickett; Andrew M Schaefer; Catherine Feeney; Alexandra Bright; Robert W Taylor; Doug M Turnbull; Grainne S Gorman; Tim Cheetham; Robert McFarland Journal: J Clin Endocrinol Metab Date: 2019-06-01 Impact factor: 5.958
Authors: Julia Dunn; Jaclyn Tamaroff; Anna DeDio; Sara Nguyen; Kristin Wade; Nicolette Cilenti; David R Weber; David R Lynch; Shana E McCormack Journal: Front Neurosci Date: 2022-03-14 Impact factor: 5.152
Authors: Tian Zhao; Caitlin Goedhart; Gerald Pfeffer; Steven C Greenway; Matthew Lines; Aneal Khan; A Micheil Innes; Timothy E Shutt Journal: Int J Mol Sci Date: 2020-11-06 Impact factor: 5.923